HemoGenyx is developing a new type of treatment for leukemia, lymphoma, and other blood disorders using a special class of cells harvested from a patient's liver that make bone marrow transplants more effective.
Company (IPO / Went public)
5 Fleet Place, London
London, EC4M 7RD
England, United Kingdom
|Investor||Investor Type||Location||Participating Rounds|
|Title||Application Date||Patent Date||Status
(Patent / Application)